The MedSurv portal

Who we are

With the MedSurv portal, we provide our customers with an online EDC system for data collection in

  • Clinical studies
  • Non-interventional studies (NIS)
  • Patient registry
  • Post-marketing observational studies
  • PMCF studies

How we work

We assist our customers all along their way - from their planning of the eCRF to the validation of the system. We also ensure that all project steps are undertaken in a well-structured sequence.

On request, we can offer a full service with reliable and internationally active partners, such as CROs, data managers, statisticians, biometrists, etc.

What makes us who we are

We offer our costumers

  • Strong project management
  • Fast response times
  • Sustainability
  • Direct and personal support

Our quality results from our certified management system. We are constantly developing ourselves and our user-friendly tools further.

Compliance

MedSurv is validated according to GAMP5 and certified according to ISO 9001. From these two processes, a well-functioning integrated management system has emerged, which has already successfully passed several audits. Our approach is based on the following guidelines and standards:

  • EU Guidelines on GxP, Annex 11 "Computer-Assisted Systems"
  • US FDA 21 CFR Part 11 - Electronic records, electronic signature
  • FDA Industry Guidelines - Computer-assisted system within the framework of clinical trials and studies
  • CDISC
  • ICH-GCP Guidelines
  • Internal SOPs as well as project-relevant SOPs of our customers

Modules

    • Tracking of changes according to legal requirements
    • Customisable algorithm
    • Reliable ratio
    • (Serious) adverse events are automatically processed
    • Virtual data check
    • Current patient and visit status
    • Management of the centres
    • Additional validation process according to DVP
    • Direct communication in the portal
    • Daily updates of study data
    • Transparency
    • Remuneration
    • Recruitment status...
    • Uploading of documents with patient allocation
    • Direct collection of questionnaires (QoL)
    • Patient diary

Testimonials

News

Post Image

15th DVMD Symposium

Building Bridges between Medicine, Biometry and Computer Science The 15th DVMD (Professional Association for Medical Documentation) symposium will take place in Düsseldorf on 5 and 6 March 2019. We will also be there with a stand for you! Further information can be found here: www.dvmd-tagung.de/
Post Image

30th Pain and Palliative Day / Frankfurt a.M.

From 07. to 09. March 2019 the 30th Pain and Palliative Day takes place in the Congress Center Messe Frankfurt. On 08.03.2019 we are back on site and look forward to an appointment with you. Further information about the congress can be found here: www.schmerz-und-palliativtag.de/
Post Image

12. medical.device.forum – We’ll be there!

On 19 and 20 March, the 12th medical.device.forum of TÜV Süd will take place in Westendstraße 199 in Munich. As in previous years, we will be there again as exhibitors. On these two days we offer you the opportunity to get to know our MedSurv portal in detail. For appointments please contact us.
Post Image

Meet us at the 65rd NRWGU

The 65rd Congress of the North-Rhine Westphalia Society for Urology e.V. (Nordrhein-Westfälischen Gesellschaft für Urologie e.V.) / NRWGU is going to take place from 28 to 29 March 2019. We`re also on site at the 28nd March. Please contact us. More informations about the congress you can find here: www.nrwgu-kongress.de
{"slides_column":"3","slides_scroll":"1","dots":"false","arrows":"true","autoplay":"true","autoplay_interval":"5000","speed":"4000","rtl":"false","loop":"true","newdesign":"design-8"}

Career

MedSurv GmbH is still looking for additional staff. Please apply for one of the following vacancies or send in your speculative application.

Softwaredeveloper (m/f/o), Apprentices Computer Sciences (m/f/o), Interns and working students (m/f/o)

Please send your application documents to Tina Biehl (job@medsurv.de). We look forward to receiving them.